Slide 1

Slide 1 text

෱ౡݝཱҩՊେֶҩֶ෦ ݈߁ϦεΫίϛϡχέʔγϣϯֶߨ࠲ ॿڭ஛ྛ༝෢ 19/10/11 42

Slide 2

Slide 2 text

•  հೖݚڀͷϙΠϯτ – ৺ཧྍ๏ʹ͓͚ΔϓϥηϘޮՌ •  ౷੍܈ઃఆͷϙΠϯτ – ࣮ફͷΤϏσϯεΛ஝ੵ͢Δ࿮૊Έ •  ୯Ұࣄྫ࣮ݧσβΠϯ •  3PVUJOF0VUDPNF.POJUPSJOH 30.

Slide 3

Slide 3 text

(RCT)

Slide 4

Slide 4 text

Murad HM et al: The New Evidence Pyramid (http://www.isehc.net/wp-content/uploads/2011/12/October-2015.pdf) 5 :

Slide 5

Slide 5 text

Murad HM et al: The New Evidence Pyramid (http://www.isehc.net/wp-content/uploads/2011/12/October-2015.pdf) 5 :

Slide 6

Slide 6 text

R C T ... ... R C T ... ... . 97 7 2 32GRADE . 65 , 2015. Guyatt G et al: J Clin Epidemiol. 2011 Apr;64(4):383-94.

Slide 7

Slide 7 text

( ) 7 ! ! ! ! ! ! Chapter 8: Assessing risk of bias in included studies (http://www.cochrane.org/handbook)

Slide 8

Slide 8 text

CBT RCT •  $VJKQFSTFUBM )JHIRVBMJUZͳ$#5ͷ3$5͸গͳ͍ ೥Ҏ߱ ೥Ҏલɿ –  ੒ਓͷ͏ͭප΍ෆ҆ʹର͢Δ$#5ͷ3$5݅ •  ରর܈͸5"6 8- QJMMQMBDFCPʹݶఆ –  ཚ਺ੜ੒ ׂΓ෇͚ͷӅณԽ ධՁऀͷ໡ݕԽ Ξ΢τΧϜଌ ఆͷ׬શੑ *55Λ࣮ࢪ͍ͯ͠Δ͔ʣΛͭΛ९क͍ͯ͠Ε ͹IJHIRVBMJUZͱ൑அ Cuijpers, P., Cristea, I. A., Karyotaki, E., Reijnders, M., & Huibers, M. J. (2016). How effecMve are cogniMve behavior therapies for major depression and anxiety disorders? A meta-analyMc update of the evidence. World Psychiatry, 15(3), 245-258.

Slide 9

Slide 9 text

CBT •  $#5͕ΰʔϧυελϯμʔυͱ͸ೝΊΒΕͳ͍ •  $#5͸ݱঢ়Ͱ͸ؒҧ͍ͳ͘ΰʔϧυελϯμʔυ Leichsenring, F., & Steinert, C. (2017). Is cogniMve behavioral therapy the gold standard for psychotherapy?: the need for plurality in treatment and research. Jama, 318(14), 1323-1324. David, D., Cristea, I., & Hofmann, S. G. (2018). Why cogniMve behavioral therapy is the current gold standard of psychotherapy. FronMers in psychiatry, 9, 4.

Slide 10

Slide 10 text

1.  2.  3.  ( TAU , 4.  5.  6.  Allegiance ( Leichsenring, F., & Steinert, C. (2017). Is cogniMve behavioral therapy the gold standard for psychotherapy?: the need for plurality in treatment and research. Jama, 318(14), 1323-1324.

Slide 11

Slide 11 text

CBT -  CBT (RCT ) -  CBT CBT -  ( -  -  TAU TAU David, D., Cristea, I., & Hofmann, S. G. (2018). Why cogniMve behavioral therapy is the current gold standard of psychotherapy. FronMers in psychiatry, 9, 4.

Slide 12

Slide 12 text

-  CBT RCT -  CBT -  de Abreu Costa, M., de Oliveira, G. S. D. A., Tacon-Ramos, T., Manfro, G. G., & Salum, G. A. (2019). Anxiety and stress-related disorders and mindfulness-based intervenMons: a systemaMc review and mulMlevel meta-analysis and meta-regression of mulMple outcomes. Mindfulness, 10(6), 996-1005.

Slide 13

Slide 13 text

CBT •  ݚڀͷ࣭͕௿͍ͱޮՌΛա৒ਪఆ 1"%΍4"%Ͱݦஶʣ 0 0.2 0.4 0.6 0.8 1 PAD SAD GAD MDD HQ All Cuijpers, P., Cristea, I. A., Karyotaki, E., Reijnders, M., & Huibers, M. J. (2016). How effecMve are cogniMve behavior therapies for major depression and anxiety disorders? A meta-analyMc update of the evidence. World Psychiatry, 15(3), 245-258.

Slide 14

Slide 14 text

CBT •  ෆ҆঱࣏ྍͷ ͏ͭප࣏ྍͰ͸͕౷ ੍܈ʹ଴ػϦετ܈ •  ଴ػϦετ౷੍܈͸$#5ͷޮՌΛաେධՁ Cuijpers, P., Cristea, I. A., Karyotaki, E., Reijnders, M., & Huibers, M. J. (2016). How effecMve are cogniMve behavior therapies for major depression and anxiety disorders? A meta-analyMc update of the evidence. World Psychiatry, 15(3), 245-258. 0 0.5 1 1.5 PAD SAD GAD MDD WL TAU Pill Placebo

Slide 15

Slide 15 text

Guidi, J., Rafanelli, C., & Fava, G. A. (2018). The clinical role of well-being therapy. Nordic journal of psychiatry, 72(6), 447-453. •  ޮՌͷա৒ਪఆ •  ϊγʔϘ OPDFCP ޮՌ •  ྙཧత໰୊ʢ࣏ྍͷ஗Ԇʣ ৺ཧྍ๏ͷ3$5ʹ͓͚Δద੾ͳ౷੍܈ͱ͸ʁ

Slide 16

Slide 16 text

: vs 16 : Enck, P., & Zipfel, S. (2019). Placebo Effects in Psychotherapy: A Framework. FronMers in Psychiatry, 10, 456.

Slide 17

Slide 17 text

: , , , , , , , , : , , , , : , , , , , , , , , , , , , , , Enck, P., & Zipfel, S. (2019). Placebo Effects in Psychotherapy: A Framework. FronMers in Psychiatry, 10, 456.

Slide 18

Slide 18 text

•  ະ࣏ྍ܈ •  ଴ػϦετ܈ •  QJMMϓϥηϘ܈ •  ௨ৗ࣏ྍ܈ •  ৺ཧֶతϓϥηϘ܈ •  ΞΫςΟϒରর܈ $#5WTༀ෺ྍ๏ͳͲ •  σΟεϚϯτϦϯά

Slide 19

Slide 19 text

Gold, S. M., Enck, P., Hasselmann, H., Friede, T., Hegerl, U., Mohr, D. C., & Oce, C. (2017). Control condiMons for randomised trials of behavioural intervenMons in psychiatry: a decision framework. The Lancet Psychiatry, 4(9), 725-732. 125 CBT RCT: WL TAU, , pill-pracebo

Slide 20

Slide 20 text

: vs 20 WLC TAU

Slide 21

Slide 21 text

࣬ױ΍࣬ױͷಛੑݚڀϑΣʔζݚڀͷ໨తೖ खՄೳͳࢿݯͷτϨʔυΦϑͰ͖·Δɻ Gold, S. M., Enck, P., Hasselmann, H., Friede, T., Hegerl, U., Mohr, D. C., & Oce, C. (2017). Control condiMons for randomised trials of behavioural intervenMons in psychiatry: a decision framework. The Lancet Psychiatry, 4(9), 725-732.

Slide 22

Slide 22 text

Gold, S. M., Enck, P., Hasselmann, H., Friede, T., Hegerl, U., Mohr, D. C., & Oce, C. (2017). Control condiMons for randomised trials of behavioural intervenMons in psychiatry: a decision framework. The Lancet Psychiatry, 4(9), 725-732. ױऀͷϦεΫ ࣬ױͷಛੑʣ ਍அͷҧ͍ ྟচతಛ௃ͷҧ͍ ౷੍܈΁ͷ༧ظ΍ظ଴ ϊηϘͷੜ͡΍͢͞ ෳ਺༗ޮͳ࣏ྍ͕͋Δ৔߹ʹ ະ࣏ྍ΍8-Λબ୒͢Δ৔߹ͷྙཧత໰୊

Slide 23

Slide 23 text

Gold, S. M., Enck, P., Hasselmann, H., Friede, T., Hegerl, U., Mohr, D. C., & Oce, C. (2017). Control condiMons for randomised trials of behavioural intervenMons in psychiatry: a decision framework. The Lancet Psychiatry, 4(9), 725-732. ྟচݚڀͷϑΣʔζ   1IBTF୳ࡧతͳ༰ྔ୳ࡧͳͲGFBTJCJMJUZ   1IBTF༧උతͳޮՌݚڀ લޙൺֱ খن໛3$5   1IBTFݕূతͳޮՌݚڀ େن໛3$5   1IBTF༗ޮੑݚڀ ࣮஍ࢼݧʣ

Slide 24

Slide 24 text

Gold, S. M., Enck, P., Hasselmann, H., Friede, T., Hegerl, U., Mohr, D. C., & Oce, C. (2017). Control condiMons for randomised trials of behavioural intervenMons in psychiatry: a decision framework. The Lancet Psychiatry, 4(9), 725-732. ྟচݚڀͷϑΣʔζ   ॳظͷ୳ࡧతͳϑΣʔζ QIBTF Ͱ͸ɺݕূΛݫີʹ͢͠ ͗ͣɺ༗๬ͳ࣏ྍΛૣ͍ͩΜ͔ΜͰݟམͱͯ͠͠·Θͳ͍Α ͏ʹ͢Δ 5ZQFΤϥʔͷճආʣɻ͜ͷஈ֊Ͱ͸8-΋͋Γɻ   ݕূతͳϑΣʔζͰ͸ɺΞΫςΟϒͳରর܈ ৺ཧతϓϥη Ϙ܈ σΟεϚϯτϦϯά౷੍܈ͳͲɺൺֱ͕ݫ֨ʢ৽ن࣏ ྍͷಛఆཁҼͷޮՌ͕໌֬ʹͳΔΑ͏౷੍܈Λઃఆʣ   ࣮஍ࢼݧ F⒎FDUJWFOFTTTUVEZ Ͱ͸ɺױऀબ୒΍࠷খ࣏ྍ ͳͲ

Slide 25

Slide 25 text

Gold, S. M., Enck, P., Hasselmann, H., Friede, T., Hegerl, U., Mohr, D. C., & Oce, C. (2017). Control condiMons for randomised trials of behavioural intervenMons in psychiatry: a decision framework. The Lancet Psychiatry, 4(9), 725-732. ݚڀࢿݯ ΞΫςΟϒͳ౷੍܈͸ίετ͕͔͔Δ հೖऀͷޏ༻ͳͲ খ͞ͳޮՌΛݕग़͢ΔͨΊʹ͸ɺେ͖ͳαϯ ϓϧαΠζ͕ඞཁ ˠαϯϓϧαΠζ࠶ਪఆ΍దԠܕσβΠϯ΋༗ޮ

Slide 26

Slide 26 text

Gold, S. M., Enck, P., Hasselmann, H., Friede, T., Hegerl, U., Mohr, D. C., & Oce, C. (2017). Control condiMons for randomised trials of behavioural intervenMons in psychiatry: a decision framework. The Lancet Psychiatry, 4(9), 725-732.   3$5ͷ࣮ࢪऀ͸ɺࢼݧͷϓϩτίϧ΍࿦จʹ ࣄલʹ౷੍܈બ୒ͷਖ਼౰ੑʹ͍ͭͯৄࡉʹه ࡌ͢΂͖   ౷੍܈ΛબͿͱ͖ɺױऀूஂͱؔ࿈ϦεΫɺ ݚڀͷϑΣʔζΛߟྀ   ϝλ෼ੳ΍࣏ྍΨΠυϥΠϯͰ౷੍܈ͷ৘ใ Λ໌ࣔ͢΂͖   ࣏ྍΨΠυϥΠϯʹɺ଴ػϦετ܈Ͱͷ3$5 Ͱ͔͠༗ޮੑ͕ࣔ͞Ε͍ͯͳ͍΋ͷ͸ܝࡌ͠ ͳ͍

Slide 27

Slide 27 text

Take home message •  ਫ਼ਆྍ๏ͷ3$5͸·ͩ·ͩݕ౼ͷ༨஍͋Γ •  ·ͩ·࣭ͩͷߴ͍3$5ͷ࣮ࢪ͕ඞཁ •  ւ֎Ͱͦ͏͍ͬͨݱঢ়ͳͷͰ͍ΘΜ΍ࠃ಺Ͱ ͸ʜ •  ਫ਼ਆྍ๏ͷ3$5Ͱ͸౷੍܈ͷઃఆ͕ॏཁ •  ױऀͷಛੑͱݚڀஈ֊ʹԠͯ͡ɺద੾ͳ౷੍ ܈ઃఆΛ •  ਫ਼ਆྍ๏ͷ3$5ͷΤϑΥʔτ͸ਙେͳͷͰɺ ֶձओಋ·ͨ͸νʔϜͰ

Slide 28

Slide 28 text

No content

Slide 29

Slide 29 text

(Research supported psychological intervenMon) •  े෼ʹཱ֬͞Ε࣏ͨྍ •  ͓ͦΒ͘ޮՌͷ͋Δ࣏ྍ •  ࣮ݧతͳ࣏ྍ Chambless, D. L., & Hollon, S. D. (1998). Defining empirically supported therapies. Journal of consulMng and clinical psychology, 66(1), 7.

Slide 30

Slide 30 text

(research supported psychological intervenMon) 1 2 ( / ) 2 ( / ) 3 4 5 Chambless, D. L., & Hollon, S. D. (1998). Defining empirically supported therapies. Journal of consulMng and clinical psychology, 66(1), 7.

Slide 31

Slide 31 text

Gold, S. M., Enck, P., Hasselmann, H., Friede, T., Hegerl, U., Mohr, D. C., & Oce, C. (2017). Control condiMons for randomised trials of behavioural intervenMons in psychiatry: a decision framework. The Lancet Psychiatry, 4(9), 725-732.   1IBTF୳ࡧతͳ༰ྔ୳ࡧͳͲGFBTJCJMJUZ   1IBTF༧උతͳޮՌݚڀ લޙൺֱ খن໛3$5 4$&%   1IBTFݕূతͳޮՌݚڀ ( RCT)   1IBTF༗ޮੑݚڀ ࣮஍ࢼݧ 4$&% ʣ

Slide 32

Slide 32 text

1 1.  ݸਓΛର৅ʹ 2.  ݸਓ಺Ͱಠཱ ม਺Λૢ࡞ 3.  Ξ΢τΞϜม ਺Λ൓෮ଌఆ Kratochwill, T. R., Hitchcock, J., Horner, R. H., Levin, J. R., Odom, S. L., Rindskopf, D. M & Shadish, W. R. (2010). Single-case designs technical documentaMon. Retrieved from What Works Clearinghouse website: hcp://ies.ed.gov/ncee/wwc/pdf/wwc_scd.pdf. ϕʔεϥΠϯ ظ A հೖظ

Slide 33

Slide 33 text

1 1.  ྟচ”࣮ફ”ͷޮՌΛՊֶతʹݕূՄೳ •  ΫϥΠΤϯτʹݱࡏ࣮ࢪ͍ͯ͠Δհೖ͕༗ޮ ͔ΛɺΫϥΠΤϯτͷ؍࡯σʔλʹج͍ͮͯ ٬؍తʹ൑அͰ͖Δ 2.  RCTͷ࣮ࢪ͕ࠔ೉ͳঢ়گͰհೖ๏ͷ༗ޮੑ ΛՊֶతʹධՁ͢Δ୅ସ๏ͱͯ͠ͷظ଴ •  ঱ྫूੵͷݱ࣮తͳࠔ೉ •  ౷੍܈΁ͷׂΓ౰ͯͷྙཧత໰୊ •  RCTࣗମͷݶքͷࢦఠ RCTͱ࣮ྟচͷױऀͱͷဃ཭΍ݸਓࠩ౳ Barlow, D. H., Nock, M., & Hersen, M. (2009). Single case experimental designs: Strategies for studying behavior for change (No. Sirsi) i9780205474554).

Slide 34

Slide 34 text

1 ࠃ·ͨ͸ֶձϨϕϧͰɺओཁͳλεΫϑΥʔε͕ɺ RCTͱڞʹɺΤϏσϯεϕʔευͳհೖɾ࣏ྍͷޮՌ ධՁʹ1ࣄྫ࣮ݧσβΠϯͷ׆༻Λਪ঑ •  ถࠃ৺ཧֶձͷྟচɺࣇಐྟচ෦ձɺֶߍ৺ཧֶ෦ձ ͷΤϏσϯεʹج͍ͮͨհೖͷλεΫϑΥʔε •  ถࠃࠃཱڭҭݚڀॴಡղҕһձ (National reading panel) •  ࠃཱڭҭධՁɾ஍ҬࢧԉηϯλʔͷWhat Works ClearinghouseʹΑΔਪ঑ Kratochwill, T. R., & Levin, J. R. (2014). Single-case intervention research: Methodological and statistical advances. American Psychological Association.

Slide 35

Slide 35 text

1 ҩֶྖҬͰͷN of 1 trial (ABABσβΠϯ)΁ͷ஫໨ •  Guyatte et al. (2000)͕JAMAץߦ࿦จͰ ΤϏσϯε֊૚ͷτοϓ •  ΞϝϦΧҩֶձ(2000)Ͱ΋ΤϏσϯε֊૚ ͷτοϓ •  Oxford center for Evidence based medicineͷΤϏσϯεϨϕϧ(2011) Ͱ”ڧݻͳΤϏσϯε”ʹ֘౰ Mirza, R. D., Punja, S., Vohra, S., & Guyac, G. (2017). The history and development of N-of-1 trials. Journal of the Royal Society of Medicine, 110(8), 330-340. Guyac, G. H., Haynes, R. B., Jaeschke, R. Z., Cook, D. J., Green, L., Naylor, C. D., ... & Evidence- Based Medicine Working Group. (2000). Users' guides to the medical literature: XXV. Evidence- based medicine: principles for applying the users' guides to paMent care. Jama, 284(10), 1290-1296.

Slide 36

Slide 36 text

Behavior Research and TherapyͰࠓ೥ͷ6݄߸ʹɺ ୯Ұࣄྫ࣮ݧσβΠϯͷಛू߸͕اը

Slide 37

Slide 37 text

1 1.  ܥ౷తͳಠཱม਺ͷૢ࡞ 2.  Ξ΢τΧϜม਺ͷଌఆ 1ਓҎ্ͷධఆऀ ධఆऀؒͷҰக཰͕Ұఆਫ४Ҏ্ (֤ϑΣʔζ20%Ҏ্ͷσʔλ࢖༻) 3.  গͳ͘ͱ΋֤ϑΣʔζ3࣌఺ͷଌఆɺ3ͭͷҟͳΔϑΣʔζ Λ൓෮ 4.  ֤ϑΣʔζ಺ͰͷϨϕϧɺ܏޲ੑɺมಈੑͷ໌ࣔ 5.  ޮՌͷ໌ࣔ ޮՌͷimmediacy / ॏෳ౓ / ϑΣʔζؒͰͷσʔλͷҰ؏ੑ ؍࡯σʔλͱ༧ଌσʔλͷύλʔϯΛൺֱ 6.  ֎తཁҼͱಛҟੑͷݕ౼ Institute of Education Sciences. (2014). What Works Clearinghouse procedures and standards handbook.

Slide 38

Slide 38 text

1ࣄྫ࣮ݧݚڀͷใࠂͷ࣭޲্ͷͨΊͷΨΠυϥΠϯͷ੔උ (SCRIBE੠໌) ݚڀͷ಺తଥ౰ੑͱ֎తଥ౰ੑΛۛຯ͢Δई౓ (RoBiNT scale) Tate, R. L., Perdices, M., Rosenkoecer, U., Wakim, D., Godbee, K., Togher, L., & McDonald, S. (2013). Revision of a method quality raMng scale for single-case experimental designs and n-of-1 trials: The 15-item Risk of Bias in N-of-1 Trials (RoBiNT) Scale. Neuropsychological rehabilitaMon, 23(5), 619-638. Tate, R. L., Perdices, M., Rosenkoecer, U., McDonald, S., Togher, L., Shadish, W., ... & Sampson, M. (2016). The Single-Case ReporMng Guideline In BEhavioural IntervenMons (SCRIBE) 2016: ExplanaMon and elaboraMon. Archives of ScienMfic Psychology, 4(1), 10.

Slide 39

Slide 39 text

1 ւ֎Ͱ͸ೖ໳ςΩετॏ൛ɺ৽نൃߦ͕࣋ଓ ೝ஌ߦಈྍ๏ͷݚڀऀ͕ࣥච

Slide 40

Slide 40 text

No content

Slide 41

Slide 41 text

No content

Slide 42

Slide 42 text

1 •  ॏෳ཰ հೖظͷಘ఺͕ ϕʔεϥΠϯͷ࠷௿ ࠷ߴ ಘ఺Ҏ্ ҎԼ Ͱ͋Δׂ߹ •  ฏۉ஋ࠩ ֤ϑΣʔζͷಘ఺ͷฏۉ Λࢉग़ࠩ͠ΛٻΊΔ Aͷ࠷௿఺=17 17఺Ҏ্ͷBͷσʔλ਺=3 ॏෳ཰=3/18 A=20 B=12 =8

Slide 43

Slide 43 text

•  ॏෳ཰ܥɿ5BV6 – ϕʔεϥΠϯͷτϨϯυͷӨڹΛߟྀ – ࣗݾ૬ؔ͸ߟྀ͞Εͳ͍ – ϊϯύϥϝτϦοΫͳࢦඪɺ෼෍ͷԾఆͳ͠ –  •  ฏۉ஋ࠩ1)4ͷඪ४ԽޮՌྔ   ෳ਺໊ͷ࣌ܥྻσʔλΛ౷߹͠ޮՌྔΛࢉग़   ࣗݾ૬ؔτϨϯυΛߟྀ   ύϥϝτϦοΫͳࢦඪ   ਖ਼ن෼෍Ҏ֎ͷ෼෍ʹ΋֦ுՄೳ Parker, R. I., Vannest, K. J., Davis, J. L., & Sauber, S. B. (2011). Combining nonoverlap and trend for single-case research: Tau- U. Behavior Therapy, 42(2), 284-299. Pustejovsky, J. E., Hedges, L. V., & Shadish, W. R. (2014). Design-comparable effect sizes in mulMple baseline designs: A general modeling framework. Journal of EducaMonal and Behavioral StaMsMcs, 39(5), 368-393.

Slide 44

Slide 44 text

PHS   ୯Ұࣄྫ࣮ݧͷ݁ՌΛɺଞͷ܈ؒൺֱσβΠ ϯͷ݁ՌͷղऍͰ׳Ε਌͠ΜͰ͍ΔޮՌྔɺ ৴པ۠ؒʹج͍ͮͯղऍͰ͖Δɻ   ಉ͡ϦαʔνΫΤενϣϯΛ࣋ͭݸʑͷ୯Ұ ࣄྫ࣮ݧͷ݁ՌΛ౷߹Ͱ͖Δɻ   ແ࡞ҝԽൺֱࢼݧͷΑ͏ͳ܈ؒൺֱࢼݧͷ݁ Ռͱ୯Ұࣄྫ࣮ݧͷ݁ՌΛൺֱͰ͖Δɻ   ୯Ұࣄྫ࣮ݧͷ݁Ռͱଞͷ܈ؒൺֱσβΠϯ ͷ஌ݟΛ౷߹Ͱ͖Δɻ Shadish, W. R., Hedges, L. V., Horner, R. H., & Odom, S. L. (2015). The Role of Between-Case Effect Size in ConducMng, InterpreMng, and Summarizing Single-Case Research. NCER 2015-002. NaMonal Center for EducaMon Research.

Slide 45

Slide 45 text

δBC = √ + 1 3 (RCT DO) ( δBC ) = Shadish, W. R., Hedges, L. V., Horner, R. H., & Odom, S. L. (2015). The Role of Between-Case Effect Size in ConducMng, InterpreMng, and Summarizing Single-Case Research. NCER 2015-002. NaMonal Center for EducaMon Research.

Slide 46

Slide 46 text

CBT : ACT : Au, T. M., Sauer-Zavala, S., King, M. W., Petrocchi, N., Barlow, D. H., & Litz, B. T. (2017). Compassion-based therapy for trauma-related shame and poscraumaMc stress: IniMal evaluaMon using a mulMple baseline design. Behavior therapy, 48(2), 207-221. Ruiz, F. J., Flórez, C. L., García-Martín, M. B., Monroy-Cifuentes, A., Barreto-Montero, K., García-Beltrán, D. M., ... & Gil-Luciano, B. (2018). A multiple-baseline evaluation of a brief acceptance and commitment therapy protocol focused on repetitive negative thinking for moderate emotional disorders. Journal of Contextual Behavioral Science.

Slide 47

Slide 47 text

CBT Au, T. M., Sauer-Zavala, S., King, M. W., Petrocchi, N., Barlow, D. H., & Litz, B. T. (2017). Compassion-based therapy for trauma- related shame and poscraumaMc stress: IniMal evaluaMon using a mulMple baseline design. Behavior therapy, 48(2), 207-221. : An overall, standardized mean difference effect size for each outcome variable was also calculated, using a d-sta:s:c specifically developed for singlecase designs (Shadish, Hedges, & Pustejovsky, 2014). The resulMng d- staMsMc takes into account autocorrelaMon, between- and within-case variance, and corrects for small sample bias using Hedges’ g. It is in the same metric as the d-staMsMc used for between-subjects designs and can be pooled with those staMsMcs in meta-analyses.

Slide 48

Slide 48 text

CBT Au, T. M., Sauer-Zavala, S., King, M. W., Petrocchi, N., Barlow, D. H., & Litz, B. T. (2017). Compassion-based therapy for trauma- related shame and poscraumaMc stress: IniMal evaluaMon using a mulMple baseline design. Behavior therapy, 48(2), 207-221. ACT : To obtain an overall esMmate of the effect size of the intervenMon, the design-comparable effect size for mulMple-baseline designs developed by Pustejovsky, Hedges, and Shadish (2014) was computed. This standardized mean difference effect size for SCED shares the same metric as the Cohen's d typically used in group designs, which facilitates the direct comparison and integraMon through meta-analysis of the results obtained in both types of designs. This d-staMsMc has a formal mathemaMcal development, requires at least three cases for computaMon, and corrects for small sample bias using Hedges’ g. It is an extension of the standardized mean difference advocated by Hedges, Pustejovsky, and Shadish (2012, 2013) that uses restricted maximum likelihood esMmaMon and offers the possibility of obtaining the d-staMsMc by controlling for baseline trend and taking into account change in slope. The R package scdhlm was used to compute this d-staMsMc (Pustejovsky, 2016) following the guidelines provided by ValenMne, Tanner- Smith, and Pustejovsky (2016). According to the global visual inspecMon of the dataset, we modelled baselines without trends including both fixed and random effects for level. The treatment phase was modelled with linear trends with both fixed and random effects at level and slope. We computed the d-staMsMc to esMmate the overall effect sizes at the 4-week follow-up (i.e., just before implemenMng the second session of the protocol) and at the 12-week follow-up.

Slide 49

Slide 49 text

1 •  ෳ਺ճͷϕʔεϥΠϯଌఆ – ʙճͷϕʔεϥΠϯ͕ඞཁͩͱ͢Δͱɺຖि਍ ࡯ʹ͘Δױऀ͞ΜʹհೖΛ։࢝͢Δ·Ͱϲ݄લ ޙ଴ػͯ͠΋ΒΘͳ͚Ε͹͍͚ͳ͍ɻۤ͠Ήױऀ ͞ΜΛલʹͯ͠଴ػΛڧ͍Δͷ͸ྙཧతʹ໰୊ɻ ˠࢪઃʹ͓͚ΔΞ΢τΧϜଌఆΛϧʔςΟϯԽ 3PVUJOFPVUDPNFNPOJUPSJOH 30. ˠΞ΢τΧϜଌఆΛߴස౓Խ ܦݧαϯϓϦϯά๏

Slide 50

Slide 50 text

RouMne outcome monitoring (ROM) •  ೔ৗྟচͰɺ঱ঢ়΍20-ͳͲɺਫ਼ਆత݈߁ʹؔΘΔࢦඪΛຖ ೔·ͨ͸ຖिͷස౓ͰධՁ͠ɺױऀ΍࣏ྍνʔϜͰڞ༗͢Δ •  30.ͷ࣮ࢪࣗମʹਫ਼ਆత݈߁ͷվળʹର͢ΔޮՌ͕͋Δ #SBUUMBOEFUBM •  ϝϯλϧΫϦχοΫͷױऀ໊Λର৅ʹ3$5 •  30.࣮ࢪ܈ͱ௨ৗ࣏ྍ܈ʹແ࡞ҝׂΓ౰ͯ •  ͍ͣΕͷ܈ͷױऀ΋ਫ਼ਆྍ๏Λఏڙ͞Εͨɻ •  30.࣮ࢪ܈͸௨ৗ࣏ྍ܈ͱൺ΂ͯɺഒΞ΢τΧϜ͕վળ Brattland, H., Koksvik, J. M., Burkeland, O., Gråwe, R. W., Klöckner, C., Linaker, O. M., ... & Iversen, V. C. (2018). The effects of routine outcome monitoring (ROM) on therapy outcomes in the course of an implementation process: A randomized clinical trial. Journal of counseling psychology, 65(5), 641. Shimokawa, K., Lambert, M. J., & Smart, D. W. (2010). Enhancing treatment outcome of patients at risk of treatment failure: meta-analytic and mega-analytic review of a psychotherapy quality assurance system. Journal of consulting and clinical psychology, 78(3), 298.

Slide 51

Slide 51 text

RouMne outcome monitoring (ROM) Van Der Lem, R., Van Der Wee, N. J., Van Veen, T., & Zitman, F. G. (2012). Efficacy versus effecMveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily pracMce. Psychotherapy and psychosomaMcs, 81(4), 226-234. 30.σʔλΛ࢖ͬͯɺ͏ͭප࣏ྍͷQIBTFݚڀ F⒎FDUJWFOFTTTUVEZ 1IBTFͷྟচࢼݧσʔλͷϝλ෼ੳσʔλͱɺ30.Ͱଌఆ͠ ͨݱ৔ͰͷΞ΢τΧϜͷ܈಺ޮՌྔ ׮ղ཰ Λൺֱ Clinical pracMce < RCT (32 vs.40–74%). Clinical pracMve < RCT (21 vs. 34–47%) : Clinical pracice < RCT (27 vs. 34–58% : Clinical pracMce < RCT (21 vs. 45–63%)

Slide 52

Slide 52 text

ROM •  ΠΪϦε*"15 – 1)2 ("% 84"4ͷϧʔςΟϯଌఆΛਪ঑ – ిࢠγεςϜͰͷσʔλͷొ࿥Λਪ঑ •  ঱ྫσʔλͷσʔλϕʔεԽ

Slide 53

Slide 53 text

0 2 1 4 1 ) 0 1 0 2 0 2 PANAS

Slide 54

Slide 54 text

2 .84 7 14 ཈͏ͭ঱ঢ়ͷඪ४తͳධՁई౓ͷ߲໨ΛεϚϗΞϓϦͰຖ೔ධՁ

Slide 55

Slide 55 text

Take ome message •  ୯Ұࣄྫ࣮ݧݚڀ๏ͷՁ஋͕ݟ௚͞ΕɺࣄྫใࠂΛ ՊֶతͳΤϏσϯεͱͯ͠൑அ͢ΔͨΊͷίϯηϯ αε͕੔උ͞Εͭͭ͋Δ •  ౷ܭղੳख๏ͷൃలʹΑΓɺ୯Ұࣄྫ࣮ݧͷϝλ෼ ੳ΋Մೳʹͳ͖͍ͬͯͯΔ •  ϧʔνϯͰΞ΢τΧϜଌఆ͢Δ͜ͱࣗମ͕ྟচతͳ ޮՌΛ࣋ͪɺͳ͓͔ͭF⒎FDUJWFOFTTTUVEZ͕࣮ࢪ ՄೳͱͳΔ͜ͱͰ࣮ફͷޮՌΛ஝ੵɺݕূՄೳ •  ܦݧαϯϓϦϯά๏౳ͷ*5ػثΛ׆༻͢Δ͜ͱͰ೔ ৗྟচ͔Β΋ղੳʹ଱͑͏Δߴີ౓ͳσʔλ͕औಘ Մೳ

Slide 56

Slide 56 text

•  ૯ྗΛ͔͚ͯ3$5Λຊ૸ΒͤΔ •  ୯Ұࣄྫ࣮ݧݚڀʹجͮ͘঱ྫใࠂ ͷਪ঑ •  ϧʔνϯଌఆʹ࢖༻Մೳͳई౓ͷਪ ঑࡞੒΍ई౓ͷඪ४Խ •  ిࢠγεςϜʹΑΔ঱ྫͷొ࿥σʔ λϕʔεԽ RCT CBT